Opportunity Information: Apply for CDC RFA IP13 1306
Apply for CDC RFA IP13 1306
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities outside the United States" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance.
- This funding opportunity was created on Mar 15, 2013 and posted on Mar 15, 2013.
- Applicants must submit their applications by May 14, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $22,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $400,000.00 in funding.
- The number of recipients for this funding is limited to 12 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Limited to selected foreign governments based on consultation with WHO and identified needs to provide support for pandemic preparedness, surveillance and outbreaks of influenza in animals or humans or those who are judged at risk of such outbreaks by HHS and the WHO Secretariat. Eligible applicants must have an active WHO National Influenza Center (NIC) recognized by the WHO Secretariat or must develop a plan or demonstrate intent towards fulfilling the terms of reference of a designation by WHO.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The CDC funding opportunity titled "Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities outside the United States" (Funding Opportunity Number CDC RFA IP13-1306) was a discretionary cooperative agreement designed to strengthen national-level preparedness and response for influenza threats in countries outside the U.S. The focus was on helping foreign governments, typically through their Ministries of Health or other ministries responsible for human health and public health emergency preparedness, improve the systems needed to detect, assess, and respond to avian influenza and potential pandemic influenza events. In practical terms, the program was aimed at boosting the capacity of national public health authorities to find influenza cases earlier, confirm them reliably, share information quickly, and coordinate an effective response when outbreaks occur in humans or when zoonotic influenza risks are rising.
This opportunity used a cooperative agreement mechanism, which generally means CDC anticipated being substantially involved in the work beyond simply providing funds. While the announcement text provided here is brief, cooperative agreements in this space typically imply close technical collaboration, alignment with international standards, and ongoing coordination with CDC on planning, implementation, monitoring, and response activities. The activity category was "Health," and the CFDA number associated with the program was 93.283 (CDC Investigations and Technical Assistance), signaling the intent to support applied public health work, technical strengthening, and operational readiness rather than basic research.
Eligibility was tightly limited. Applications were not open broadly to NGOs, universities, or general applicants; instead, they were restricted to selected foreign governments identified based on consultation with the World Health Organization (WHO) and assessed needs related to pandemic preparedness, influenza surveillance, and outbreak response. Countries could also be selected if they were judged at risk for influenza outbreaks in animals or humans by the U.S. Department of Health and Human Services (HHS) and the WHO Secretariat. A key eligibility condition was that the applicant country must have an active WHO National Influenza Center (NIC) recognized by the WHO Secretariat, or otherwise present a plan or clear intent to meet the WHO terms of reference to become designated. This NIC requirement highlights the central role of laboratory and surveillance infrastructure that fits within the WHO Global Influenza Surveillance and Response System framework, including the ability to detect and characterize influenza viruses and to communicate findings in a way that supports global risk assessment.
The funding scale indicates a mid-sized, multi-country capacity-building effort. CDC projected about 12 awards, with an estimated total funding level of $22,000,000. Individual awards were expected to range from $100,000 (floor) to $400,000 (ceiling), and there was no cost sharing or matching requirement. These award sizes suggest the grants were meant to fund targeted, practical improvements such as strengthening sentinel and event-based surveillance, improving outbreak investigation capacity, enhancing laboratory diagnostics and virus characterization, supporting data reporting and integration, and building readiness activities that allow faster detection and response to emerging influenza threats. Because influenza outbreaks can spread quickly and cross borders, the program logic is consistent with improving both national resilience and international health security by ensuring that at-risk countries can detect novel strains early and communicate actionable information promptly.
The opportunity was posted on March 15, 2013, with an original and final closing date of May 14, 2013, and it was archived on June 13, 2013. For access issues related to the full announcement, CDC directed applicants to the Procurement and Grants Office Technical Information Management Section (TIMS) via phone (770-488-2700) or email (pgotim@cdc.gov).
Frequently Asked Questions (FAQs)
What is this CDC funding opportunity?
This opportunity is the CDC discretionary cooperative agreement titled "Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities outside the United States" (Funding Opportunity Number CDC RFA IP13-1306). It was designed to strengthen national-level preparedness and response for avian influenza and potential pandemic influenza threats in countries outside the United States.
What is the main goal of the program?
The program aimed to help national public health authorities improve the systems needed to detect, assess, and respond to influenza threats. In practical terms, it focused on enabling earlier detection of influenza cases, reliable confirmation, rapid information sharing, and coordinated response to outbreaks in humans or rising zoonotic influenza risks.
Who was the intended applicant audience?
Applications were restricted to selected foreign governments, typically through their Ministries of Health or other ministries responsible for human health and public health emergency preparedness. The opportunity was not open broadly to general applicants.
Were NGOs, universities, or other non-government entities eligible to apply directly?
No. Based on the information provided, eligibility was tightly limited and not open broadly to NGOs, universities, or general applicants. It was restricted to selected foreign governments identified through consultation and assessed needs.
How were eligible countries selected?
Eligible countries were identified based on consultation with the World Health Organization (WHO) and assessed needs related to pandemic preparedness, influenza surveillance, and outbreak response. Countries could also be selected if judged at risk for influenza outbreaks in animals or humans by the U.S. Department of Health and Human Services (HHS) and the WHO Secretariat.
What is the WHO National Influenza Center (NIC) requirement?
A key eligibility condition was that the applicant country must have an active WHO National Influenza Center (NIC) recognized by the WHO Secretariat, or present a plan or clear intent to meet the WHO terms of reference to become designated as an NIC.
Why does the opportunity emphasize a WHO National Influenza Center (NIC)?
The NIC requirement underscores the central role of laboratory and surveillance capacity aligned with the WHO Global Influenza Surveillance and Response System. This includes the ability to detect and characterize influenza viruses and communicate findings to support global risk assessment.
What type of funding mechanism was used?
The award used a cooperative agreement mechanism. This generally means CDC anticipated substantial involvement in the work beyond simply providing funds, with close technical collaboration and ongoing coordination on planning, implementation, monitoring, and response activities.
What is the activity category for this funding?
The activity category was Health.
What is the CFDA number associated with this opportunity?
The CFDA number associated with the program was 93.283 (CDC Investigations and Technical Assistance).
What does CFDA 93.283 suggest about the nature of supported work?
It signals an intent to support applied public health work, technical strengthening, and operational readiness rather than basic research.
How many awards did CDC expect to make?
CDC projected about 12 awards.
What was the estimated total funding level?
The estimated total funding level was $22,000,000.
What was the expected award amount per recipient?
Individual awards were expected to range from $100,000 (floor) to $400,000 (ceiling).
Was cost sharing or matching required?
No. There was no cost sharing or matching requirement stated for this opportunity.
What kinds of activities were the awards intended to support?
Based on the description provided, awards were meant to fund targeted, practical improvements such as strengthening sentinel and event-based surveillance, improving outbreak investigation capacity, enhancing laboratory diagnostics and virus characterization, supporting data reporting and integration, and building readiness activities to enable faster detection and response to emerging influenza threats.
What types of influenza threats were addressed?
The focus was on avian influenza and potential pandemic influenza events, including situations where outbreaks occur in humans and where zoonotic influenza risks are rising.
Where was this program intended to operate?
It was intended for national health authorities outside the United States.
When was the opportunity posted?
The opportunity was posted on March 15, 2013.
What were the application closing dates?
The original and final closing date was May 14, 2013.
When was the opportunity archived?
The opportunity was archived on June 13, 2013.
What should someone do if they had trouble accessing the full announcement?
For access issues related to the full announcement, CDC directed applicants to contact the Procurement and Grants Office Technical Information Management Section (TIMS) by phone at 770-488-2700 or by email at pgotim@cdc.gov.
What government offices or international organizations were referenced in determining eligibility?
The opportunity referenced consultation with WHO, including the WHO Secretariat, and risk judgments by the U.S. Department of Health and Human Services (HHS).
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: State Offices of Rural Health Grant Program (SORH)
Previous opportunity: Nationwide Program for National and State Background Checks for Direct Patient Access Employees of Long Term Care Facilities and Providers 9th Announcement
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA IP13 1306
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA IP13 1306) also looked into and applied for these:
| Funding Opportunity |
|---|
| State Offices of Rural Health Grant Program (SORH) Apply for HRSA 13 162 Funding Number: HRSA 13 162 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Introducing or Expanding the Use of Seasonal Influenza Vaccines in Public Health Programs Outside of the United States Apply for CDC RFA IP13 1305 Funding Number: CDC RFA IP13 1305 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
| Developing Research Capacity to Assess Health Effects Associated with Volcanic Emissions and other Environmental Exposures (R01) Apply for RFA EH 13 002 Funding Number: RFA EH 13 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| National Center for HIV/AIDS, Viral Hepatitis, Sexually Transmitted Diseases and Tuberculosis Prevention, Public Health Conference Support Apply for CDC RFA PS13 1305 Funding Number: CDC RFA PS13 1305 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| National Center for Environmental Health/Agency for Toxic Substances and Disease Registry Public Health Conference Support Program Apply for CDC RFA EH13 1306 Funding Number: CDC RFA EH13 1306 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $100,000 |
| NIBIB Biomedical Technology Resource Centers (P41) Apply for PAR 13 144 Funding Number: PAR 13 144 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development of Animal Models and Related Biological Materials for Research (R21) Apply for PA 13 145 Funding Number: PA 13 145 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Promoting, Strengthening and Enhancing Disease Prevention by Collaboration with Targeted Stakeholders Apply for CDC RFA IP13 1303 Funding Number: CDC RFA IP13 1303 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $220,000 |
| USAID/Vietnam Request for Information (RFI) on Healthy Markets Activity Apply for SOL 486 13 00022 Funding Number: SOL 486 13 00022 Agency: Thailand USAID Bangkok Category: Health Funding Amount: $15,000,000 |
| Cooperative Centers on Human Immunology (U19) Apply for RFA AI 13 016 Funding Number: RFA AI 13 016 Agency: National Institutes of Health Category: Health Funding Amount: $1,750,000 |
| Limited Competition Dominantly Inherited Alzheimer Network (U19) Apply for PAR 13 147 Funding Number: PAR 13 147 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition Biomarkers for Older Controls at Risk for Dementia (BIOCARD) Study (U19) Apply for PAR 13 148 Funding Number: PAR 13 148 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Organizations for Chronic Disease Prevention Apply for CDC RFA DP10 10080401SUPP13 Funding Number: CDC RFA DP10 10080401SUPP13 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $230,000 |
| NIAID Clinical Trial Implementation Grant (R01) Apply for PAR 13 149 Funding Number: PAR 13 149 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID Clinical Trial Planning Grant (R34) Apply for PAR 13 150 Funding Number: PAR 13 150 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| NIAID Clinical Trial Implementation Cooperative Agreement (U01) Apply for PAR 13 151 Funding Number: PAR 13 151 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Aging Research Dissertation Awards to Increase Diversity (R36) Apply for PAR 13 152 Funding Number: PAR 13 152 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development and Characterization of Animal Models for Aging Research (R01) Apply for PA 13 155 Funding Number: PA 13 155 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development and Characterization of Animal Models for Aging Research (R21) Apply for PA 13 156 Funding Number: PA 13 156 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Using Evidence from Science and Community Practice to Develop Web and other Technology Based Tools for HIV Treatment Service Provider Organizations to Improve Linkage, Retention, and Re Engagement of HIV Positive Persons in Care Apply for CDC RFA PS13 1311 Funding Number: CDC RFA PS13 1311 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA IP13 1306", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.